Fundación Española De Hematología Y Hemoterapía

This study aims to validate a new, fully automated blood test (HemosIL AcuStar) for diagnosing and monitoring acquired thrombotic thrombocytopenic purpura (aTTP), a rare but life-threatening blood clotting disorder. Researchers will compare the new test's accuracy against current…